Our focus is on elucidation of the nartural history of selected lysosomal storage disorders (LSD) and development of therapy for these conditions. We are engaged in Clinical trials at the Rivergate Site, and in the Laboratory conduct molecular and biochemical investigations to characterize the underlying gene defects and pathogenetic mechanisms asscoaited with various LSDs.